Fleury Group is one of the largest health companies in Brazil, focusing on diagnostic medicine. Its main activities involve the provision of a wide range of laboratory and imaging tests, as well as highly complex diagnostics and precision medicine. The company operates through an integrated ecosystem that encompasses several brands, such as Fleury, a+, Hermes Pardini and others, serving different market segments. The company's business model is divided into two main fronts: Care Units, which provide services directly to patients, and B2B Operations, which offers diagnostic solutions for hospitals, laboratories and other health companies. With a national presence, the group operates an extensive network of care units, partner hospitals and laboratories in several Brazilian states.
Type | Record Date | Excluding Date | Payment | Value (R$) |
|---|---|---|---|---|
JCP | 8/12/2025 | 8/13/2025 | 10/3/2025 | 0,26 |
Dividend | 3/6/2025 | 3/7/2025 | 5/9/2025 | 0,47 |
JCP | 12/13/2024 | 12/16/2024 | 12/27/2024 | 0,18 |
JCP | 8/14/2024 | 8/15/2024 | 10/2/2024 | 0,29 |
Dividend | 3/19/2024 | 3/20/2024 | 4/1/2024 | 0,15 |
JCP | 12/15/2023 | 12/18/2023 | 12/28/2023 | 0,23 |
JCP | 9/4/2023 | 9/5/2023 | 10/31/2023 | 0,14 |
JCP | 12/19/2022 | 12/20/2022 | 12/29/2022 | 0,25 |
Dividend | 3/22/2022 | 3/23/2022 | 4/4/2022 | 0,71 |
JCP | 12/20/2021 | 12/21/2021 | 12/30/2021 | 0,08 |
JCP | 8/3/2021 | 8/4/2021 | 8/16/2021 | 0,11 |
Dividend | 3/2/2021 | 3/3/2021 | 4/1/2021 | 0,49 |
JCP | 1/6/2021 | 1/7/2021 | 3/5/2021 | 0,20 |
Dividend | 2/26/2020 | 2/27/2020 | 4/3/2020 | 0,62 |
JCP | 1/2/2020 | 1/3/2020 | 1/17/2020 | 0,10 |
JCP | 7/30/2019 | 7/31/2019 | 10/4/2019 | 0,17 |